Effect of BAriatric Surgery Versus Optimal Medical Therapy on Cardiovascular Health and Atherosclerosis in Obese, Type II Diabetic Patients

NCT02331420 | Unknown

• 1 other identifier: 4569/14
• Study Type: interventional
• Target: 58
• Locations: 0 countries
• Sites: N/A

Brief Summary

To assess the impact of weight loss due to bariatric surgery, as compared to the effect of optimal medical therapy alone on endothelial function, subclinical atherosclerosis, cardiovascular autonomic function in obese patient affected by type 2 diabetes.The study consists in a 2-arm randomized trial, in which patients will be randomly assigned to bariatric surgery or optimal medical therapy. Each patient will be studied at baseline (T0) and 12 months thereafter (T1).

Conditions

Obesity; Diabetes Mellitus, Type 2; Atherosclerosis

Outcome Measures

Primary Outcomes (3)

• Subclinical Atherosclerosis (ecographic assessment of carotid artery intima-media thickness)

  ecographic assessment of carotid artery intima-media thickness

  12 months

• Endothelial Function (ecographic assessment of flow-mediated dilation and nitrate mediated dilation)

  ecographic assessment of flow-mediated dilation and nitrate mediated dilation

  12 months

• Cardiac autonomic function (heart rate variability measurements on 24-hour Holter ECG recordings)

  heart rate variability measurements on 24-hour Holter ECG recordings

  12 months

Study Arms (2)

Bariatric Surgery

EXPERIMENTAL

Gastric bypass

Procedure: Gastric bypass

Optimal Medical Therapy

ACTIVE COMPARATOR

planned visits, optimized hypoglycemic treatment, diet and lifestyle modification

Behavioral: Medical therapy

Interventions

Gastric bypass PROCEDURE

A subcardial gastric pouch with a 30±10 ml capacity will be created by sectioning the stomach with a linear stapler 3-4 cm horizontally on the lesser curve, 4 cm distal to the e-g junction, and then vertically until attainment of the angle of Hiss. After identification of the Treitz ligament, the jejunum will be transected at 100 cm from the ligament of Treitz and the two stumps will be closed. The distal stump will be anastomosed to the distal end of the gastric pouch. The preferred gastro-jejunal anastomosis is the totally hand-sewn one, but it can be performed using any other the technique the surgeon is more familiar with. Finally, the proximal stump of the transacted bowel will be joined end-to-side to the jejunum 150 cm distal to the gastro-enterostomy.

Bariatric Surgery

Medical therapy BEHAVIORAL

* Assessment and treatment by a multidisciplinary team (diabetologist, dietitian, nurse); * Planned visits at baseline and at 1, 3, 6, 9, 12, and 24 months after study entry; * Oral hypoglycemic agents and insulin doses optimized on an individual basis with the aim of reaching a glycated hemoglobin level of less than 7%; * Programs for diet and lifestyle modification, including reduced overall energy and fat intake (\<30% total fat, \<10% saturated fat, and high fiber content) and increased physical exercise (≥30 minutes of brisk walking every day, possibly associated with moderate-intensity aerobic activity twice a week); * low-calorie diet (every day: 50% carbohydrate, 30% protein and 20% lipids).

Optimal Medical Therapy

Eligibility Criteria

• Age: 40 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• type 2 diabetes: the American Diabetes Association (ADA) recommends the following criteria for diagnosis of diabetes: HbA1c ≥6.5% OR fasting plasma glucose‡ ≥126 mg/dL (7.0 mmol/L) OR 2-hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during an oral glucose tolerance test; 75-g glucose load should be used OR random plasma glucose concentration ≥200 mg/dL (11.1 mmol/L) in persons with symptoms of hyperglycemia or hyperglycemic crisis;
• indication to bariatric surgery: BMI ≥35 kg/m2 and one or more obesity related co-morbidities, including Type 2 Diabetes Mellitus.

You may not qualify if:

• overt cardiovascular disease (as assessed by clinical evaluation, physical examination, 12-lead ECG, 2D-echocardiogram);
• smoking habit;
• associated medical conditions, as chronic kidney disease (defined as creatinine clearance \<60 mL/min/L.73m2), liver cirrhosis, malignancies, chronic congestive heart failure, acute or chronic inflammatory disease;
• specific contraindication to bariatric surgery;
• pregnancy;
• medical conditions requiring acute hospitalization;
• psychological conditions which may hamper patient's cooperation;
• geographic inaccessibility.

Sponsors & Collaborators

• Catholic University of the Sacred Heart: lead

MeSH Terms

Conditions

Obesity; Diabetes Mellitus, Type 2; Atherosclerosis

Interventions

Gastric Bypass; Nutrition Therapy

Condition Hierarchy (Ancestors)

Overweight; Overnutrition; Nutrition Disorders; Nutritional and Metabolic Diseases; Body Weight; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Diabetes Mellitus; Glucose Metabolism Disorders; Metabolic Diseases; Endocrine System Diseases; Arteriosclerosis; Arterial Occlusive Diseases; Vascular Diseases; Cardiovascular Diseases

Intervention Hierarchy (Ancestors)

Bariatric Surgery; Bariatrics; Obesity Management; Therapeutics; Gastroenterostomy; Anastomosis, Surgical; Surgical Procedures, Operative; Digestive System Surgical Procedures

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: DIAGNOSTIC
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: January 2, 2015
• First Posted: January 6, 2015
• Study Start: February 1, 2015
• Primary Completion: January 1, 2017
• Study Completion: July 1, 2017
• Last Updated: January 6, 2015

Record last verified: 2015-01